WUXAY vs. TEVA

Last updated Apr 2, 2026

Compare and contrast key facts about WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA).

Performance

WUXAY vs. TEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA). The values are adjusted to include any dividend payments, if applicable.

WUXAY vs. TEVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WUXAY WuXi AppTec Co. Ltd	20.46%	84.22%	-26.59%	-0.53%	-41.47%	-20.12%
TEVA Teva Pharmaceutical Industries Limited	-3.08%	41.61%	111.11%	14.47%	13.86%	-29.24%

Fundamentals

EPS WUXAY : $10.02 TEVA : $1.21
PE Ratio WUXAY : 1.52 TEVA : 25.03
PEG Ratio WUXAY : 0.04 TEVA : 0.19
PS Ratio WUXAY : 0.64 TEVA : 2.04
Total Revenue (TTM) WUXAY : $45.38B TEVA : $17.26B
Gross Profit (TTM) WUXAY : $21.54B TEVA : $8.94B
EBITDA (TTM) WUXAY : $24.00B TEVA : $3.80B

Returns By Period

In the year-to-date period, WUXAY achieves a 20.46% return, which is significantly higher than TEVA's -3.08% return.

WUXAY

• 1D: -0.07%
• 1M: 2.70%
• YTD: 20.46%
• 6M: -0.91%
• 1Y: 81.15%
• 3Y*: 17.57%
• 5Y*: -3.24%
• 10Y*: —

TEVA

• 1D: 0.43%
• 1M: -10.42%
• YTD: -3.08%
• 6M: 50.80%
• 1Y: 97.84%
• 3Y*: 50.64%
• 5Y*: 21.38%
• 10Y*: -5.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WUXAY vs. TEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WUXAY

WUXAY Risk / Return Rank: 80
WUXAY Sharpe Ratio Rank: 83
WUXAY Sortino Ratio Rank: 78
WUXAY Omega Ratio Rank: 78
WUXAY Calmar Ratio Rank: 80
WUXAY Martin Ratio Rank: 81

TEVA

TEVA Risk / Return Rank: 92
TEVA Sharpe Ratio Rank: 93
TEVA Sortino Ratio Rank: 92
TEVA Omega Ratio Rank: 91
TEVA Calmar Ratio Rank: 92
TEVA Martin Ratio Rank: 92

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WUXAY vs. TEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WuXi AppTec Co. Ltd (WUXAY) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WUXAY	TEVA	Difference
Sharpe ratio Return per unit of total volatility	1.48	2.33	-0.85
Sortino ratio Return per unit of downside risk	2.06	3.11	-1.05
Omega ratio Gain probability vs. loss probability	1.28	1.42	-0.15
Calmar ratio Return relative to maximum drawdown	2.47	4.44	-1.98
Martin ratio Return relative to average drawdown	6.97	12.93	-5.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WUXAY vs. TEVA - Sharpe Ratio Comparison

The current WUXAY Sharpe Ratio is 1.48, which is lower than the TEVA Sharpe Ratio of 2.33. The chart below compares the historical Sharpe Ratios of WUXAY and TEVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WUXAY	TEVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.48	2.33	-0.85
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.50	-0.55
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.11	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.07	0.31	-0.38

Correlation

The correlation between WUXAY and TEVA is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WUXAY vs. TEVA - Dividend Comparison

WUXAY's dividend yield for the trailing twelve months is around 2.74%, while TEVA has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
WUXAY WuXi AppTec Co. Ltd	2.74%	3.30%	1.93%	1.24%	0.76%	0.23%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TEVA Teva Pharmaceutical Industries Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.88%	3.19%	1.77%

Drawdowns

WUXAY vs. TEVA - Drawdown Comparison

The maximum WUXAY drawdown since its inception was -84.50%, smaller than the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for WUXAY and TEVA.

Drawdown Indicators

	WUXAY	TEVA	Difference
Max Drawdown Largest peak-to-trough decline	-84.50%	-90.89%	+6.39%
Max Drawdown (1Y) Largest decline over 1 year	-31.85%	-21.79%	-10.06%
Max Drawdown (5Y) Largest decline over 5 years	-84.50%	-43.70%	-40.80%
Max Drawdown (10Y) Largest decline over 10 years	—	-88.71%	—
Current Drawdown Current decline from peak	-29.62%	-55.29%	+25.67%
Average Drawdown Average peak-to-trough decline	-47.88%	-31.90%	-15.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.43%	7.49%	+3.94%

Volatility

WUXAY vs. TEVA - Volatility Comparison

WuXi AppTec Co. Ltd (WUXAY) has a higher volatility of 13.92% compared to Teva Pharmaceutical Industries Limited (TEVA) at 11.82%. This indicates that WUXAY's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WUXAY	TEVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.92%	11.82%	+2.10%
Volatility (6M) Calculated over the trailing 6-month period	32.48%	27.30%	+5.18%
Volatility (1Y) Calculated over the trailing 1-year period	55.18%	42.20%	+12.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	71.84%	42.76%	+29.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	71.27%	47.20%	+24.07%

Financials

WUXAY vs. TEVA - Profitability Comparison

The chart below illustrates the profitability comparison between WuXi AppTec Co. Ltd and Teva Pharmaceutical Industries Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

WUXAY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, WuXi AppTec Co. Ltd reported a gross profit of 6.34B and revenue of 12.60B. Therefore, the gross margin over that period was 50.3%.

TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 2.66B and revenue of 4.71B. Therefore, the gross margin over that period was 56.4%.

WUXAY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, WuXi AppTec Co. Ltd reported an operating income of 4.99B and revenue of 12.60B, resulting in an operating margin of 39.6%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported an operating income of 1.27B and revenue of 4.71B, resulting in an operating margin of 26.9%.

WUXAY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, WuXi AppTec Co. Ltd reported a net income of 7.08B and revenue of 12.60B, resulting in a net margin of 56.2%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported a net income of 480.00M and revenue of 4.71B, resulting in a net margin of 10.2%.